Home / Generics

Generics

News

Endo removes Opana ER opioid from the market posted 18/08/2017

The US Food and Drug Administration (FDA) requested that Endo International plc (Endo) remove its opioid medication Opana ER...

Impax launches new high-strength ADHD generics posted 18/08/2017

Impax Laboratories Inc (Impax) has received US Food and Drug Administration (FDA) approval for additional strength capsules o...

FDA approval for generics of ADHD drug Strattera posted 23/06/2017

The US Food and Drug Administration announced on 30 May 2017 the approval of the first generic versions of Strattera (atomoxe...

FDA approves two new Seroquel XR generics posted 16/06/2017

The US Food and Drug Administration (FDA) has approved two generic versions of Astra Zeneca’s antidepressant Seroquel XR, whi...

Vytorin generic launched in the US posted 26/05/2017

The US Food and Drug Administration (FDA) has approved a generic version of the anti-cholesterol drug Vytorin, which will be...

 

Research

Generics prices increase when competition decreases posted 11/08/2017

A US-based retrospective cohort study has found that generics prices increase when competition is low or non-existent [1].

Follow-up study finds generic tacrolimus safe for kidney transplant patients posted 14/07/2017

Researchers from Portugal, who carried out a long-term follow-up study, have found that switching stable kidney transplant pa...

Generics in the pipeline for 2017 in the US posted 14/07/2017

Since the Hatch-Waxman Act was passed in 1984, the approval process for generics has been simplified. The law created an abbr...

Oncology drug pricing – the case of generic imatinib posted 09/06/2017

Authors Christopher Chen and Aaron Kesselheim review how various market strategies slowed the entry of generics of leukaemia...

Generic substitution of antiretroviral drugs in Ireland: healthcare provider views posted 02/06/2017

A survey conducted in Ireland shows that most healthcare providers consider the generic substitution of antiretroviral drugs...

 

General

WHO prequalifies first generic hepatitis C drug posted 18/08/2017

The World Health Organization (WHO) has pre-qualified the first generic drug to treat hepatitis C. The antiviral agent sofosb...

AAM tries to block ‘unconstitutional’ drug pricing law posted 18/08/2017

The Association for Accessible Medicines (AAM) has filed a lawsuit against the Attorney General of Maryland in an attempt to...

FDA lists drugs without generics to increase competition posted 07/07/2017

The US Food and Drug Administration (FDA) announced on 27 June 2017 that it had taken ‘two new, important steps’ to increase...

UK introduces new law to control generic drug prices posted 30/06/2017

A new law introduced in the UK is seeking to clarify and extend the government’s powers to regulate the cost of medicines and...

Baxter and Dorizoe make deal for generic injectables posted 23/06/2017

US-based healthcare company Baxter International (Baxter) and contract research and development organization Dorizoe announce...